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Total	 	 3294	 20,394*	 16.6%	
*The	total	number	of	prescriptions	reviewed	was	20,517,	however	some	entries	have	missing	bandings	
**The	consultant	pharmacists	were	graded	at	bands	8b	and	8c	
	
	
	
	
	
	
 
